We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 22
Most popular |Most recent


HHS watchdog eyes anti-kickback safe harbors for care coordination, beneficiary incentives, and cost-sharing

USA - August 29 2018 On Monday, the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) published a wide-ranging Request for Information...

David E. Thiess, Thomas Beimers, Sheree R. Kanner, Ronald L. Wisor, JR., Jonathan Diesenhaus, Eliza L. Andonova, Helen R. Trilling, Craig H. Smith.


New Jersey Issues Rules to Chill Drug Manufacturer Payments to Prescribers

USA - January 10 2018 The New Jersey Attorney General plans to finalize new limits on payments and other benefits that New Jersey licensed prescribers may accept from...

Thomas Beimers, Laura McDonald, Ronald L. Wisor, JR., Meredith Manning, Eliza L. Andonova, Helen R. Trilling.


New California Law Limits Drug Manufacturer Co-Pay Cards and Other Discounts in California

USA - October 16 2017 In the most recent salvo by states eager to show an effort to contain prescription drug costs, California's governor has signed into law a bill that...

Laura McDonald, Ronald L. Wisor, JR., Eliza L. Andonova, Helen R. Trilling.


A path forward: Corportate Integrity Agreement sheds light on manufacturer interactions with independent charitable foundations

USA - October 2 2017 Manufacturers of pharmaceuticals and biologics have been closely watching the industry-wide investigation by the Boston U.S. Attorney's Office into...

Thomas Beimers, Sheree R. Kanner, Ronald L. Wisor, JR., Eliza L. Andonova, Helen R. Trilling.


New Jersey Joins Wave of States Proposing New Rules for Drug Marketing and HCP Interactions

USA - September 11 2017 Drug manufacturers are once again facing new state limits on marketing and interactions with healthcare providers. Manufacturers should review the new...

Ronald L. Wisor, JR., Eliza L. Andonova, Helen R. Trilling.